Cargando…
Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
OBJECTIVE: To assess the long-term cost-effectiveness of aspirin use among adults aged ≥40 years with newly diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: We used a validated cost-effectiveness model of type 2 diabetes to assess the lifetime health and cost consequences of use or nonuse of...
Autores principales: | Li, Rui, Zhang, Ping, Barker, Lawrence E., Hoerger, Thomas J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875422/ https://www.ncbi.nlm.nih.gov/pubmed/20332350 http://dx.doi.org/10.2337/dc09-1888 |
Ejemplares similares
-
Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes
por: Hoerger, Thomas J., et al.
Publicado: (2010) -
Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
por: Hoerger, Thomas J., et al.
Publicado: (2013) -
Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational Diabetes
por: Neuwahl, Simon J., et al.
Publicado: (2022) -
Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
por: Sinha, Anushua, et al.
Publicado: (2010) -
Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis
por: Gillett, M, et al.
Publicado: (2010)